Correction - GENFIT: Unblinding of Phase 3 RESOLVE-IT Data Deferred
GENFIT S.A. - American Depositary Shares (GNFT)
Company Research
Source: GlobeNewswire
CORRECTION GENFIT: Unblinding of Phase 3 RESOLVE-IT Data Deferred This release is being issued to correctly state that the Phase 3 RESOLVE-IT trial remains blinded. This release replaces the previously issued one in its entirety. Lille (France), Cambridge (Massachusetts, United States), February 20, 2020 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, today announced that unblinding of the Phase 3 RESOLVE-IT data will be delayed to incorporate the latest FDA insights expected by the end of March. Topline interim results will be announced in the weeks following receipt of FDA insight. This decision has been taken to ensure that the latest thinking in the NASH field is properly captured so the Company can optimize elafibranor’s NDA dossier at the time of submission. At this stage the trial remains blinded, meaning this
Show less
Read more
Impact Snapshot
Event Time:
GNFT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GNFT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GNFT alerts
High impacting GENFIT S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GNFT
News
- GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023) [Yahoo! Finance]Yahoo! Finance
- GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)GlobeNewswire
- GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents [Yahoo! Finance]Yahoo! Finance
- GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory DocumentsGlobeNewswire
- GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F [Yahoo! Finance]Yahoo! Finance